SGLT2 inhibitor administration to two patients with diabetes mellitus with ascites due to cirrhosis
We used the sodium-glucose cotransporter 2 inhibitor, luseogliflozin in two patients with diabetes mellitus with Child–Pugh classification B cirrhosis and cirrhotic ascites. In each case, luseogliflozin was safely used for over three years and was also considered effective in reducing ascites. In on...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Bioscientifica
2025-07-01
|
| 叢編: | Endocrinology, Diabetes & Metabolism Case Reports |
| 主題: | |
| 在線閱讀: | https://edm.bioscientifica.com/view/journals/edm/2025/3/EDM-25-0015.xml |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|